Related Experiment Video
Updated: Aug 8, 2026

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
Published on: November 6, 2018
The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor
Sadanori Akita1, Kozo Akino, Toshifumi Imaizumi
1Division of Plastic and Reconstructive Surgery, Department of Developmental and Reconstructive Medicine, Nagasaki University, Graduate School of Biomedical and Sciences, Nagasaki, Japan.
Insights
Basic fibroblast growth factor (bFGF) treatment significantly improved scarring in pediatric second-degree burn patients. This advanced healing led to better scar appearance and function compared to conventional methods.
Area of Science:
- Regenerative Medicine
- Pediatric Burn Care
- Wound Healing Research
Background:
- Pediatric second-degree burns present challenges in accurate evaluation and can lead to significant scarring.
- Delayed healing of pediatric burns often results in hypertrophic scars, impacting both aesthetics and function.
- Basic fibroblast growth factor (bFGF) is a cytokine with demonstrated efficacy in accelerating wound healing.
Purpose of the Study:
- To investigate the effects of basic fibroblast growth factor (bFGF) on the scarring of second-degree pediatric burn wounds.
- To compare the scar quality and skin barrier function in pediatric burn patients treated with bFGF versus conventional methods.
Main Methods:
- A comparative study involving 20 pediatric patients (8 months to 3 years) with second-degree burns.
- Patients were divided into two groups: conventional treatment (n=10) and treatment with bFGF (n=10).
- Scar assessment included clinical evaluation (pigmentation, pliability, height, vascularity) and objective measurements using a moisture meter at least one year post-healing.
Main Results:
- bFGF-treated scars showed significant improvements in pigmentation, pliability, height, and vascularity compared to conventional treatment (P < .01).
- Objective moisture meter analysis revealed significantly less transepidermal water loss (TEWL) in bFGF-treated wounds (P < .01).
- The effective contact coefficient was significantly lower in bFGF-treated wounds, indicating better stratum corneum function.
Conclusions:
- Basic fibroblast growth factor (bFGF) treatment enhances the healing of pediatric second-degree burn wounds, leading to improved scar quality.
- bFGF therapy positively impacts both the clinical appearance and objective measures of skin barrier function post-healing.
- These findings suggest bFGF is a promising therapeutic agent for minimizing detrimental scarring in pediatric burn patients.
Abstract:
Pediatric burn wounds can be problematic because an accurate evaluation is difficult as the result of anatomically immature vasculature or immobilization failure, especially in patients with second-degree burns, and because the burn surface areas and the burn depth tend to worsen over the course of time. Delayed wound healing results in unsightly scarring, such as hypertrophic scars, which are problematic both esthetically and functionally. Among cytokines and growth factors, basic fibroblast growth factor (bFGF) is clinically proven, having demonstrated accelerated acute and chronic wound healing. Accelerated wound healing may lead to improved scarring. To elucidate the effects of bFGF on second-degree pediatric burn wounds, a comparative study was performed. A total of 20 pediatric patients ranging from 8 month to 3 years (average 1 year, 3 months +/- 6 months) who suffered from the burns by various causes were divided into two groups, conventional (n = 10) and treatment with bFGF (n = 10). A moisture meter, used to objectively measure the stratum corneum and epithelial-mesenchymal functions, was used to assess scars at least 1 year after wound healing. Clinical evaluation of pigmentation, pliability, height, and vascularity demonstrated significant differences between conventional and bFGF-treated scars (1.7 +/- 0.55 vs 0.7 +/- 0.58, 2.4 +/- 0.82 vs 1.1 +/- 0.69, 1.8 +/- 0.66 vs 0.5 +/- 0.57, 1.9 +/- 0.63 vs 0.8 +/- 0.68; conventional vs bFGF-treated, pigmentation, pliability, height, and vascularity, respectively, P < .01). The effective contact coefficient was significantly greater in conventional wounds than bFGF-treated wounds (14.6 +/- 1.68 % vs 8.7 +/- 2.82 %; conventional vs bFGF, P < .01) and bFGF-treated wounds demonstrated significantly less transepidermal water loss values than conventional treatment (8.3 +/- 1.90 g/m/h vs 5.7 +/- 1.85 g/m/hr; conventional vs bFGF, P < .01). Pediatric burn patients treated with bFGF showed less damaging function of the stratum corneum after healing both in clinical assessment and moisture meter analysis.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Healing II: Complications
Introduction to Fibroblasts
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...

